NewAmsterdam Pharma N.V.

NASDAQ: NAMS · Real-Time Price · USD
19.51
0.12 (0.62%)
At close: Jun 05, 2025, 3:59 PM
19.07
-2.26%
After-hours: Jun 05, 2025, 06:28 PM EDT

NewAmsterdam Pharma Revenue

NewAmsterdam Pharma reported an annual revenue of $45.56M, reflecting a 257% growth. For the quarter ending March 31, 2025, NewAmsterdam Pharma generated $2.98M in revenue.
Revenue (ttm)
$45.56M
Revenue Growth
257%
Price / Sales Ratio
53.22
Revenue / Employee
$670.04K
Employees
68
Market Cap
2.19B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.